Next Article in Journal
Low-Cost Microfluidic Mixers: Are They up to the Task?
Previous Article in Journal
Correction: van den Born-Bondt et al. Development of an Adaptable Qualification Test Set for Personnel Involved in Visual Inspection Procedures of Parenteral Drug Products Manufactured Under Good Manufacturing Practice Conditions in Hospital Pharmacy Compounding Facilities. Pharmaceutics 2025, 17, 74
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Optimization of a Newly Developed Chamber Setup for Spatial Dust Measurements in the Context of Containment

by
Hendrik Küllmar
1,
Martin Schöler
2 and
Claudia S. Leopold
1,*
1
Division of Pharmaceutical Technology, University of Hamburg, Bundesstr. 45, 20146 Hamburg, Germany
2
Fette Compacting GmbH, Grabauer Straße 24, 21493 Schwarzenbek, Germany
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(5), 565; https://doi.org/10.3390/pharmaceutics17050565
Submission received: 14 March 2025 / Revised: 19 April 2025 / Accepted: 23 April 2025 / Published: 25 April 2025
(This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices)

Abstract

Background/Objectives: A specially designed chamber setup for containment investigations of pharmaceutical dusts was recently developed. The aim of the present study was to optimize the measurement procedure with this chamber setup, focusing on the atomization parameters. The optimization was aimed at a maximization of the amount of detected dust and a minimization of the required sample mass. Methods: For this purpose, the safe surrogate substance acetaminophen was used for dust measurements. In addition to the atomization parameters investigated by a design of experiments, the cleaning of the chamber setup and the selection of two different types of acetaminophen with different physicochemical properties were examined. Results: By altering the cleaning method of the chamber setup, more than a tenfold increase of detected acetaminophen was observed. In addition, by selecting the more appropriate acetaminophen type, the totally detected acetaminophen amount was further increased by more than 25%. By means of the design of experiments two models were developed, one dealing with the atomization parameters with regard to the atomization effectiveness and the other describing their influence on the spatial dust distribution of acetaminophen. Based on the model for atomization effectiveness, the totally detected acetaminophen amount may be increased by more than double at a constant sample mass. Conclusions: In summary, the measurement procedure of the chamber setup was optimized in terms of the cleaning method, surrogate choice, and the adjustment of the atomization parameters, giving valuable insights to deepen our understanding of dustiness and the spatial distribution of dust in the context of containment.
Keywords: containment; dustiness chamber; IOM sampler; spatial dust distribution design of experiments containment; dustiness chamber; IOM sampler; spatial dust distribution design of experiments

Share and Cite

MDPI and ACS Style

Küllmar, H.; Schöler, M.; Leopold, C.S. Optimization of a Newly Developed Chamber Setup for Spatial Dust Measurements in the Context of Containment. Pharmaceutics 2025, 17, 565. https://doi.org/10.3390/pharmaceutics17050565

AMA Style

Küllmar H, Schöler M, Leopold CS. Optimization of a Newly Developed Chamber Setup for Spatial Dust Measurements in the Context of Containment. Pharmaceutics. 2025; 17(5):565. https://doi.org/10.3390/pharmaceutics17050565

Chicago/Turabian Style

Küllmar, Hendrik, Martin Schöler, and Claudia S. Leopold. 2025. "Optimization of a Newly Developed Chamber Setup for Spatial Dust Measurements in the Context of Containment" Pharmaceutics 17, no. 5: 565. https://doi.org/10.3390/pharmaceutics17050565

APA Style

Küllmar, H., Schöler, M., & Leopold, C. S. (2025). Optimization of a Newly Developed Chamber Setup for Spatial Dust Measurements in the Context of Containment. Pharmaceutics, 17(5), 565. https://doi.org/10.3390/pharmaceutics17050565

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop